down arrow

Venus Remedies

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE411B01019
  • NSEID: VENUSREM
  • BSEID: 526953
INR
305.00
8.1 (2.73%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 5.99 k

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

303.00305.95

52 Week

272.20427.30
Valuation
Technical
Day's Volume

CASH

5.99 k (-75.56%) Volume

Shareholding (Dec 2024)

FII

1.11%

Held by 4 FIIs

DII

0.00%

Held by 0 DIIs

Promoter

41.76%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
1

Stock is technically in a Bearish range

  • The technical trend has deteriorated from Mildly Bearish on 07-Apr-25 and has generated 4.81% returns since then
  • The stocks MACD and Bollinger Band technical factors are also Bearish
stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Pharmaceuticals & Drugs

stock-summary
Market cap

INR 408 Cr (Micro Cap)

stock-summary
P/E

15.00

stock-summary
Industry P/E

33

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.19

stock-summary
Return on Equity

4.47%

stock-summary
Price to Book

0.80

Revenue and Profits (1 Year):
Net Sales:
177 Cr
(Quarterly Results - Dec 2024)
Net Profit:
20 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
6 Months
-7.58%
0%
-7.58%
1 Year
-10.02%
0%
-10.02%
2 Years
56.13%
0%
56.13%
3 Years
-13.77%
0%
-13.77%
4 Years
6.09%
0%
6.09%
5 Years
1029.63%
0%
1029.63%

Latest dividend: 3 per share ex-dividend date: Sep-23-2013

Risk Adjusted Returns v/s Sensex stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
13.19%
EBIT Growth (5y)
98.02%
EBIT to Interest (avg)
19.23
Debt to EBITDA (avg)
1.14
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
1.11
Tax Ratio
40.20%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
1.11%
ROCE (avg)
5.41%
ROE (avg)
6.04%
Valuation key factors
Factor
Value
P/E Ratio
15
Industry P/E
33
Price to Book Value
0.80
EV to EBIT
10.02
EV to EBITDA
5.62
EV to Capital Employed
0.76
EV to Sales
0.47
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
5.70%
ROE (Latest)
4.47%
Tecnicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Mildly Bearish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
Mildly Bullish
Mildly Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Non Institution

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 4 FIIs (1.11%)

Promoter with highest holding

Sunev Pharma Solutions Limited (17.21%)

Highest Public shareholder

Mc Jain Infoservices Private Limited (2.32%)

Individual Investors Holdings

45.42%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'24 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Dec 2024 is 23.32% vs 22.69% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Dec 2024 is 186.13% vs 108.21% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "176.86",
          "val2": "143.42",
          "chgp": "23.32%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "18.36",
          "val2": "12.04",
          "chgp": "52.49%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.01",
          "val2": "0.07",
          "chgp": "-85.71%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "9.91",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "19.60",
          "val2": "6.85",
          "chgp": "186.13%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "10.38%",
          "val2": "8.39%",
          "chgp": "1.99%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Consolidated) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2024 is 5.02% vs -7.10% in Sep 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": " Growth in half year ended Sep 2024 is -57.37% vs -9.00% in Sep 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "276.06",
          "val2": "262.87",
          "chgp": "5.02%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "16.18",
          "val2": "28.19",
          "chgp": "-42.60%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.04",
          "val2": "0.12",
          "chgp": "-66.67%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "4.74",
          "val2": "11.12",
          "chgp": "-57.37%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "5.86%",
          "val2": "10.72%",
          "chgp": "-4.86%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 11.48% vs 1.61% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 35.45% vs 15.86% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "452.92",
          "val2": "406.29",
          "chgp": "11.48%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "34.54",
          "val2": "40.23",
          "chgp": "-14.14%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.05",
          "val2": "0.19",
          "chgp": "-73.68%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "9.91",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "24.34",
          "val2": "17.97",
          "chgp": "35.45%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "7.63%",
          "val2": "9.90%",
          "chgp": "-2.27%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2024 is 8.27% vs -7.44% in Mar 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2024 is 7.23% vs -34.79% in Mar 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'24",
        "Mar'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "601.45",
          "val2": "555.51",
          "chgp": "8.27%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "59.60",
          "val2": "60.02",
          "chgp": "-0.70%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.09",
          "val2": "0.12",
          "chgp": "-25.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "28.48",
          "val2": "26.56",
          "chgp": "7.23%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "9.91%",
          "val2": "10.80%",
          "chgp": "-0.89%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Dec'24 - YoYstock-summary
Dec'24
Dec'23
Change(%)
Net Sales
176.86
143.42
23.32%
Operating Profit (PBDIT) excl Other Income
18.36
12.04
52.49%
Interest
0.01
0.07
-85.71%
Exceptional Items
9.91
0.00
Consolidate Net Profit
19.60
6.85
186.13%
Operating Profit Margin (Excl OI)
10.38%
8.39%
1.99%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in quarter ended Dec 2024 is 23.32% vs 22.69% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Dec 2024 is 186.13% vs 108.21% in Dec 2023

All Quarterly Resultsstock-summary
Half Yearly Results Snapshot (Consolidated) - Sep'24stock-summary
Sep'24
Sep'23
Change(%)
Net Sales
276.06
262.87
5.02%
Operating Profit (PBDIT) excl Other Income
16.18
28.19
-42.60%
Interest
0.04
0.12
-66.67%
Exceptional Items
0.00
0.00
Consolidate Net Profit
4.74
11.12
-57.37%
Operating Profit Margin (Excl OI)
5.86%
10.72%
-4.86%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

Growth in half year ended Sep 2024 is 5.02% vs -7.10% in Sep 2023

Direction Arrows
Consolidated Net Profit

Growth in half year ended Sep 2024 is -57.37% vs -9.00% in Sep 2023

All Half Yearly Resultsstock-summary
Nine Monthly Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
452.92
406.29
11.48%
Operating Profit (PBDIT) excl Other Income
34.54
40.23
-14.14%
Interest
0.05
0.19
-73.68%
Exceptional Items
9.91
0.00
Consolidate Net Profit
24.34
17.97
35.45%
Operating Profit Margin (Excl OI)
7.63%
9.90%
-2.27%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2024 is 11.48% vs 1.61% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in nine months ended Dec 2024 is 35.45% vs 15.86% in Dec 2023

All Nine Monthly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Mar'24stock-summary
Mar'24
Mar'23
Change(%)
Net Sales
601.45
555.51
8.27%
Operating Profit (PBDIT) excl Other Income
59.60
60.02
-0.70%
Interest
0.09
0.12
-25.00%
Exceptional Items
0.00
0.00
Consolidate Net Profit
28.48
26.56
7.23%
Operating Profit Margin (Excl OI)
9.91%
10.80%
-0.89%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2024 is 8.27% vs -7.44% in Mar 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2024 is 7.23% vs -34.79% in Mar 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Venus Remedies Ltd stock-summary
stock-summary
Venus Remedies Ltd
Micro Cap
Pharmaceuticals & Drugs
Incorporated in 1989 Venus Remedies Ltd (formerly known Venus Glucose Pvt Ltd), was converted into Public Limited Company in 1994 and then changed into Venus Remedies Limited. The Company was promoted and managed by Chaudhary & Family. The Company is one of the handful player in pharmaceutical sector to launch injectables globally. It has manufacturing facilities in Panchkula and Baddi , and research and development centre under the name of Venus Medicine Research Centre (in India).
Company Coordinates stock-summary
Company Details
S C No 857 Cabin No 10 2nd Flr, N A C Manimajra Chandigarh Chandigarh ( U T ) : 160101
stock-summary
Tel:
stock-summary
http://www.venusremedies.com
stock-summary
investorgrievance@venusremedies.co.
Registrar Details
Link Intime India Pvt Ltd, A-40, 2nd Floor, Naraina Industrial Area , Phase II, Near Batra Banquet Hall, New Delhi
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."